ENTRY       D07667                      Drug
NAME        Cevimeline (INN)
FORMULA     C10H17NOS
EXACT_MASS  199.1031
MOL_WEIGHT  199.3131
CLASS       Neuropsychiatric agent
             DG01490  Muscarinic cholinergic receptor agonist
             DG01719  Parasympathomimetic agent
            Metabolizing enzyme substrate
             DG01644  CYP2D6 substrate
             DG01633  CYP3A/CYP3A4 substrate
              DG02913  CYP3A4 substrate
REMARK      ATC code: N07AX03
            Chemical structure group: DG00993
            Product (DG00993): D00661<JP/US>
EFFICACY    Salivation accelaletor, Muscarinic acetylcholine receptor agonist
COMMENT     Arecoline derivative
TARGET      CHRM3 [HSA:1131] [KO:K04131]
  PATHWAY   hsa04080(1131)  Neuroactive ligand-receptor interaction
            hsa04725(1131)  Cholinergic synapse
            hsa04970(1131)  Salivary secretion
METABOLISM  Enzyme: CYP2D6 [HSA:1565], CYP3A4 [HSA:1576]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N07 OTHER NERVOUS SYSTEM DRUGS
               N07A PARASYMPATHOMIMETICS
                N07AX Other parasympathomimetics
                 N07AX03 Cevimeline
                  D07667  Cevimeline (INN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01490  Muscarinic cholinergic receptor agonist
               DG00993  Cevimeline
                D07667  Cevimeline
              DG01719  Parasympathomimetic agent
               DG00993  Cevimeline
                D07667  Cevimeline
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00993  Cevimeline
                D07667  Cevimeline
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00993  Cevimeline
                 D07667  Cevimeline
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Acetylcholine (muscarinic)
                CHRM3
                 D07667  Cevimeline (INN)
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D07667
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01490  Muscarinic cholinergic receptor agonist
               DG00993  Cevimeline
              DG01719  Parasympathomimetic agent
               DG00993  Cevimeline
             Metabolizing enzyme substrate
              DG01644  CYP2D6 substrate
               DG00993  Cevimeline
              DG01633  CYP3A/CYP3A4 substrate
               DG02913  CYP3A4 substrate
                DG00993  Cevimeline
DBLINKS     CAS: 107233-08-9
            PubChem: 51091969
            ChEBI: 3568
            LigandBox: D07667
            NIKKAJI: J1.049.900C
ATOM        13
            1   C1z C    24.2900  -17.4300
            2   C1y C    24.2900  -16.0300
            3   C1x C    23.0300  -18.2000
            4   C1x C    23.0300  -15.2600
            5   C1x C    23.4500  -16.8700
            6   N1y N    21.7700  -17.4300
            7   C1x C    21.7700  -16.0300
            8   C1x C    22.7500  -16.3800
            9   O2x O    24.2900  -18.8300
            10  C1y C    25.6900  -19.3200
            11  S2x S    26.5300  -18.1300
            12  C1x C    25.6900  -16.9400
            13  C1a C    26.1100  -20.6500
BOND        15
            1     1   2 1
            2     1   3 1
            3     2   4 1
            4     2   5 1
            5     3   6 1
            6     4   7 1
            7     5   8 1
            8     6   7 1
            9     6   8 1
            10    1   9 1 #Up
            11    9  10 1
            12   10  11 1
            13   11  12 1
            14    1  12 1
            15   10  13 1 #Down
///
